Mologic

Home/Mologic

About Mologic

This author has not yet filled in any details.
So far Mologic has created 17 blog entries.

Mologic Developing Sepsis Test Using Multimarker Lateral Flow Technology

By |2020-04-06T16:02:36+01:00September 20th, 2019|

Sep 20, 2019 | Leo O'Connor NEW YORK – Mologic is developing a multimarker point-of care diagnostic test using lateral flow technology that it anticipates launching in Europe next year. The diagnostic test, which is being evaluated as part of a University College London Hospitals (UCLH) study, is part [...]

Mologic and University College London Hospitals collaborating in major clinical trial for early detection of sepsis

By |2020-04-06T16:00:12+01:00September 13th, 2019|

Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis Observational study led by Mervyn Singer, Professor of Intensive Care Medicine and Dr David Brealey, Consultant in Intensive Care Bedfordshire, UK, 13 September 2019: Mologic Ltd, a leading developer of lateral flow and [...]

Mologic achieves breakthrough in ultra-sensitive point-of-care diagnostics and develops new platform technology

By |2020-04-06T15:53:13+01:00May 7th, 2019|

Visually-read device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics Since 2016, the Bill & Melinda Gates Foundation has committed $9.7 million to establish and accelerate the CARD technology programme Bedfordshire, UK, 7 May 2019: Mologic Ltd, a leading developer of [...]

Mologic expands US and UK operations

By |2019-04-10T16:27:20+01:00April 1st, 2019|

Strengthens team as part of continued international expansion Bolsters US presence with the opening of subsidiary in Boston, MA Doubles device manufacturing capacity in UK Bedfordshire, UK, 1 April 2019: Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it [...]

FIND LAUNCHES NEW SCHISTOSOMIASIS PROGRAMME

By |2019-03-14T15:22:04+00:00March 14th, 2019|

Today the Foundation for Innovative New Diagnostics (FIND) is leading a consortium, of which Mologic is part, announced the launch of a new schistosomiasis programme within its neglected tropical disease portfolio. FIND is leading a consortium which along with the WHO is developing novel rapid diagnostic tests for schistosomiasis infection that affects over 206 million people across 78 tropical and sub-tropical countries

Load More Posts
Go to Top